OR (95% CI) | p-value | |
---|---|---|
Clinical factors | ||
Male vs. Female | 1.287 (0.595–2.780) | 0.522 |
Body weight | 1.007 (0.972–1.044) | 0.706 |
Age | 0.988 (0.950–1.027) | 0.528 |
Corrected 3D-IRA at early phase | 0.817 (0.716–0.933) | 0.003 |
Corrected 3D-IRA at delayed phase | 0.932 (0.806–1.078) | 0.344 |
Pathological factors | ||
Others vs. Adenocarcinoma | 0.838 (0.397–1.769) | 0.643 |
pSize | 1.123 (1.052–1.200) | < 0.001 |
Differentiation grade | 1.505 (0.899–2.521) | 0.120 |